ABIONYX Pharma S.A.

ABIONYX Pharma S.A.verified

ABNX.PA

Price:

$3.505

Market Cap:

$121.68M

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metab...[Read more]

Industry

Biotechnology

IPO Date

2015-03-30

Stock Exchange

PAR

Ticker

ABNX.PA

The Enterprise Value as of December 2025 (TTM) for ABIONYX Pharma S.A. (ABNX.PA) is 122.42M

According to ABIONYX Pharma S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 122.42M. This represents a change of 208.21% compared to the average of 39.72M of the last 4 quarters.

ABIONYX Pharma S.A. (ABNX.PA) Historical Enterprise Value (quarterly & annually)

How has ABNX.PA Enterprise Value performed in the past?

The mean historical Enterprise Value of ABIONYX Pharma S.A. over the last ten years is 53.57M. The current 122.42M Enterprise Value has changed 22.75% with respect to the historical average. Over the past ten years (40 quarters), ABNX.PA's Enterprise Value was at its highest in in the December 2015 quarter at 189.42M. The Enterprise Value was at its lowest in in the June 2019 quarter at -1875668.00.

Quarterly (TTM)
Annual

Average

53.57M

Median

38.38M

Minimum

-206137.00

Maximum

174.70M

ABIONYX Pharma S.A. (ABNX.PA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ABIONYX Pharma S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 340.62%

Maximum Annual Enterprise Value = 174.70M

Minimum Annual Increase = -6469.75%

Minimum Annual Enterprise Value = -206137.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202439.62M6.65%
202337.15M-22.81%
202248.13M-16.82%
202157.85M340.62%
202013.13M-6469.75%
2019-206137.00-106.54%
20183.15M-87.46%
201725.14M-81.64%
2016136.98M-21.59%
2015174.70M-19.30%

ABIONYX Pharma S.A. (ABNX.PA) Average Enterprise Value

How has ABNX.PA Enterprise Value performed in the past?

The current Enterprise Value of ABIONYX Pharma S.A. (ABNX.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

41.63M

5-year avg

39.18M

10-year avg

53.57M

ABIONYX Pharma S.A. (ABNX.PA) Enterprise Value vs. Peers

How is ABNX.PA’s Enterprise Value compared to its peers?

ABIONYX Pharma S.A.’s Enterprise Value is less than OSE Immunotherapeutics S.A. (125.94M), less than Innate Pharma S.A. (124.13M), less than Adocia S.A. (133.26M), less than Genfit S.A. (285.61M), greater than Sensorion S.A. (57.66M), less than Transgene S.A. (139.51M), greater than Crossject S.A. (119.64M), less than Cellectis S.A. (388.38M), greater than MaaT Pharma S.A. (63.60M), less than Median Technologies S.A. (151.25M),

CompanyEnterprise ValueMarket cap
125.94M$112.67M
124.13M$150.80M
133.26M$128.97M
285.61M$254.21M
57.66M$102.76M
139.51M$125.72M
119.64M$108.30M
388.38M$300.87M
63.60M$64.23M
151.25M$116.57M

Build a custom stock screener for ABIONYX Pharma S.A. (ABNX.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABIONYX Pharma S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ABIONYX Pharma S.A. (ABNX.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ABIONYX Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ABIONYX Pharma S.A.'s Enterprise Value?

What is the highest Enterprise Value for ABIONYX Pharma S.A. (ABNX.PA)?

What is the 3-year average Enterprise Value for ABIONYX Pharma S.A. (ABNX.PA)?

What is the 5-year average Enterprise Value for ABIONYX Pharma S.A. (ABNX.PA)?

How does the current Enterprise Value for ABIONYX Pharma S.A. (ABNX.PA) compare to its historical average?